nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
|
Cooper, Lauren |
|
|
|
1 |
p. |
artikel |
2 |
Analytical and clinical performances of seven direct detection assays for SARS-CoV-2
|
Matsumura, Yasufumi |
|
|
|
1 |
p. |
artikel |
3 |
An epidemiological prospective of focal outbreak of dengue infection in Kathmandu, Nepal
|
Saud, Bhuvan |
|
|
|
1 |
p. |
artikel |
4 |
A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination
|
Greene, Sarah E. |
|
|
|
1 |
p. |
artikel |
5 |
Borderline and weakly positive antibody levels against the S-protein of SARS-CoV-2 exhibit limited agreement with virus neutralization titres
|
Egger, Alexander E. |
|
|
|
1 |
p. |
artikel |
6 |
Case series of HIV SARS-CoV-2 co-infection in Chinese adults
|
Ng, Rita Wai-Yin |
|
|
|
1 |
p. |
artikel |
7 |
Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation
|
Chao, Tai-Ling |
|
|
|
1 |
p. |
artikel |
8 |
Clinical performance of the Xpert® Xpress Flu/RSV assay for the detection of influenza A, B, and respiratory syncytial virus on ESwab™ medium
|
Gast, Karin B. |
|
|
|
1 |
p. |
artikel |
9 |
Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria
|
Iriemenam, Nnaemeka C. |
|
|
|
1 |
p. |
artikel |
10 |
Comparison of serum and plasma viral load measurements in human immunodeficiency virus type 1 infection
|
Mouna, Lina |
|
|
|
1 |
p. |
artikel |
11 |
Comparison of the incidence of severe outcomes in outpatients with COVID-19 or seasonal influenza without risk factors: Retrospective analysis of a health insurance claims-database
|
Oshitani, H. |
|
|
|
1 |
p. |
artikel |
12 |
Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines
|
Focosi, Daniele |
|
|
|
1 |
p. |
artikel |
13 |
Diagnosis of HIV infection using mass community rapid testing in Santiago, Chile
|
Ferrer, Pablo |
|
|
|
1 |
p. |
artikel |
14 |
Evaluation of loop-mediated isothermal amplification for detecting COVID-19
|
Giantini, Astuti |
|
|
|
1 |
p. |
artikel |
15 |
Evaluation of STANDARDTM M10 SARS-CoV-2 assay as a diagnostic tool for SARS-CoV-2 in nasopharyngeal or oropharyngeal swab samples
|
Parakatselaki, Maria-Eleni |
|
|
|
1 |
p. |
artikel |
16 |
Fast and reliable real life data on COVID-19 triaging with ID NOW
|
Burdino, Elisa |
|
|
|
1 |
p. |
artikel |
17 |
Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
|
Dhochak, Nitin |
|
|
|
1 |
p. |
artikel |
18 |
Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients
|
Hassan, Jaythoon |
|
|
|
1 |
p. |
artikel |
19 |
Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screening
|
Tsoi, Wai-Chiu |
|
|
|
1 |
p. |
artikel |
20 |
Performance evaluation of the bio-rad BioPlex 2200 multiplex system in the detection of measles, mumps, rubella, and varicella-zoster antibodies
|
Lafrenière, Matthew A. |
|
|
|
1 |
p. |
artikel |
21 |
Protective immunity in a sample of healthy adults following vaccination with a more cost effective recombinant HBsAg vaccine
|
Noordeen, Faseeha |
|
|
|
1 |
p. |
artikel |
22 |
SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients
|
Anjos, Déborah |
|
|
|
1 |
p. |
artikel |
23 |
Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination
|
Dulipsingh, Latha |
|
|
|
1 |
p. |
artikel |
24 |
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
|
Stroffolini, Giacomo |
|
|
|
1 |
p. |
artikel |
25 |
The incidence of infectious diseases and viruses other than SARS-CoV-2 amongst hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020–2021
|
Knudsen, Per Kristian |
|
|
|
1 |
p. |
artikel |
26 |
The new normal post emergence of SARS-CoV-2
|
Moore, Catherine |
|
|
|
1 |
p. |
artikel |
27 |
Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
|
Aijaz, Javeria |
|
|
|
1 |
p. |
artikel |